{"id":"https://openalex.org/W2159192124","doi":"https://doi.org/10.1093/jac/dkm376","title":"Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus","display_name":"Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus","alternate_titles":[],"publication_year":2007,"publication_date":"2007-10-03","ids":{"openalex":"https://openalex.org/W2159192124","doi":"https://doi.org/10.1093/jac/dkm376","mag":"2159192124","pmid":"https://pubmed.ncbi.nlm.nih.gov/17956908"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkm376","doi":"https://doi.org/10.1093/jac/dkm376","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkm376","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2159192124"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084807800","display_name":"Christopher McGuigan","orcid":"https://orcid.org/0000-0001-8409-710X","observed_orcids":["https://orcid.org/0000-0001-8409-710X"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. McGuigan","raw_affiliation_strings":["Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3XF, UK. mcguigan@cardiff.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3XF, UK. mcguigan@cardiff.ac.uk","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025211740","display_name":"Ranjith N. Pathirana","orcid":"https://orcid.org/0000-0003-0838-5163","observed_orcids":["https://orcid.org/0000-0003-0838-5163"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. N. Pathirana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089764806","display_name":"Marco Migliore","orcid":"https://orcid.org/0000-0003-1271-7220","observed_orcids":["https://orcid.org/0000-0003-1271-7220"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Migliore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017102765","display_name":"Rina Adak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Adak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000303788","display_name":"G Luoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Luoni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050585535","display_name":"Arwyn Tomos Jones","orcid":"https://orcid.org/0000-0003-2781-8905","observed_orcids":["https://orcid.org/0000-0003-2781-8905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. T. Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003875755","display_name":"Alberto Diez\u2010Torrubia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Diez-Torrubia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029939214","display_name":"Mar\u00eda\u2010Jos\u00e9 Camarasa","orcid":"https://orcid.org/0000-0002-4978-6468","observed_orcids":["https://orcid.org/0000-0002-4978-6468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.-J. Camarasa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079011979","display_name":"Sonsoles Vel\u00e1zquez","orcid":"https://orcid.org/0000-0003-2209-1751","observed_orcids":["https://orcid.org/0000-0003-2209-1751"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Velazquez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110183299","display_name":"Geoffrey W. Henson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Henson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111882966","display_name":"Erik K. Verbeken","orcid":"https://orcid.org/0000-0002-8776-1069","observed_orcids":["https://orcid.org/0000-0002-8776-1069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Verbeken","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071409697","display_name":"Rebecca Sienaert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Sienaert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081640914","display_name":"Lieve M. J. Naesens","orcid":"https://orcid.org/0000-0001-9742-9302","observed_orcids":["https://orcid.org/0000-0001-9742-9302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Naesens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085228034","display_name":"Robert Snoeck","orcid":"https://orcid.org/0000-0002-7586-5434","observed_orcids":["https://orcid.org/0000-0002-7586-5434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Snoeck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030479730","display_name":"Graciela Andre\u00ef","orcid":"https://orcid.org/0000-0003-2609-4896","observed_orcids":["https://orcid.org/0000-0003-2609-4896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Andrei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038319371","display_name":"Jan M. Balzarini","orcid":"https://orcid.org/0000-0003-2240-3321","observed_orcids":["https://orcid.org/0000-0003-2240-3321","https://orcid.org/0000-0003-1144-1808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Balzarini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":4.8713,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.95243339,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"60","issue":"6","first_page":"1316","last_page":"1330"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/varicella-zoster-virus","display_name":"varicella-zoster virus","score":0.9679999947547913},{"id":"https://openalex.org/keywords/herpes-zoster","display_name":"herpes zoster","score":0.6240000128746033},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.7549999952316284},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6549999713897705},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8389999866485596},{"id":"https://openalex.org/keywords/water-solubility","display_name":"water solubility","score":0.8629999756813049},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8799999952316284},{"id":"https://openalex.org/keywords/captisol","display_name":"Captisol","score":0.5419999957084656},{"id":"https://openalex.org/keywords/cellular-uptake","display_name":"cellular uptake","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2776159415","wikidata":"https://www.wikidata.org/wiki/Q6868","display_name":"Varicella zoster virus","level":3,"score":0.7290912866592407},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6484165787696838},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5977759957313538},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5615663528442383},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5583128929138184},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5383006930351257},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.5127569437026978},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4961610734462738},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4423525333404541},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3935006558895111},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.30943581461906433},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2976980209350586},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18728157877922058},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011741","descriptor_name":"Pyrimidine Nucleosides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011741","descriptor_name":"Pyrimidine Nucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011741","descriptor_name":"Pyrimidine Nucleosides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014645","descriptor_name":"Herpesvirus 3, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1093/jac/dkm376","doi":"https://doi.org/10.1093/jac/dkm376","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkm376","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:17956908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17956908","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkm376v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkm376v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkm376v2","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkm376v2","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1020.5701","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1020.5701","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jac.oxfordjournals.org/content/early/2007/11/07/jac.dkm376.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1022.2344","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1022.2344","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jac.oxfordjournals.org/content/early/2007/10/22/jac.dkm376.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320350","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1969953165","https://openalex.org/W1975234436","https://openalex.org/W1980075357","https://openalex.org/W1984594055","https://openalex.org/W1986236331","https://openalex.org/W2015699368","https://openalex.org/W2025975417","https://openalex.org/W2033339802","https://openalex.org/W2055755036","https://openalex.org/W2058705907","https://openalex.org/W2061242953","https://openalex.org/W2061974719","https://openalex.org/W2083950387","https://openalex.org/W2103504219","https://openalex.org/W2111649383","https://openalex.org/W2119462245","https://openalex.org/W2325993641","https://openalex.org/W2523461105","https://openalex.org/W2950029938","https://openalex.org/W2952194143"],"related_works":["https://openalex.org/W2102489589","https://openalex.org/W2119919568","https://openalex.org/W4224314167","https://openalex.org/W2013295296","https://openalex.org/W2114022332","https://openalex.org/W2523821537","https://openalex.org/W2114321275","https://openalex.org/W4205146299","https://openalex.org/W774042943"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"progress":[2],"the":[3,12,29,75,125,143,166,170,189,195,216,231,236],"anti-varicella-zoster-virus":[4],"(VZV)":[5],"aryl":[6,32],"bicyclic":[7],"nucleoside":[8],"analogues":[9],"(BCNAs)":[10],"to":[11,28,100,163,206],"point":[13],"of":[14,39,53,71,77,85,115,130,146,169,201,218,238],"Phase":[15],"1":[16],"clinical":[17,232],"trial":[18],"for":[19,235],"herpes":[20],"zoster.":[21],"METHODS:":[22],"A":[23,139],"new":[24],"chromatography-free":[25],"synthetic":[26],"access":[27],"lead":[30,40],"anti-VZV":[31,37,108],"BCNAs":[33],"is":[34,191,226],"reported.":[35],"The":[36,159],"activity":[38],"Cf1743":[41,98,147],"was":[42,65,165],"evaluated":[43],"in":[44,59,208],"monolayer":[45],"cell":[46],"cultures":[47,52],"and":[48,61,74,89,94,142,184,203,222],"organotypic":[49],"epithelial":[50],"raft":[51],"primary":[54],"human":[55],"keratinocytes.":[56],"Oral":[57],"dosing":[58],"rodents":[60],"preliminary":[62],"pharmacokinetics":[63],"assessment":[64],"made,":[66],"followed":[67],"by":[68,113,120,194],"an":[69],"exploration":[70],"alternative":[72],"formulations":[73],"preparation":[76],"pro-drugs.":[78],"We":[79],"also":[80],"studied":[81,180],"uptake":[82,177],"into":[83,178],"cells":[84,179,196],"both":[86],"parent":[87],"drug":[88,207],"pro-drug":[90,145,162],"using":[91,181],"fluorescent":[92,182],"microscopy":[93,183],"biological":[95,185],"assays.":[96],"RESULTS:":[97],"proved":[99],"be":[101],"significantly":[102,155],"more":[103],"potent":[104],"than":[105],"all":[106],"reference":[107],"compounds":[109],"as":[110,174,230],"measured":[111],"either":[112],"inhibition":[114],"infectious":[116],"virus":[117],"particles":[118],"and/or":[119],"viral":[121],"DNA":[122],"load.":[123],"However,":[124],"very":[126],"low":[127],"water":[128,150],"solubility":[129,151],"this":[131],"compound":[132,190],"gave":[133],"poor":[134],"oral":[135,157],"bioavailability":[136],"(approximately":[137],"14%).":[138],"Captisol":[140],"admixture":[141],"5'-monophosphate":[144],"greatly":[148],"boosted":[149],"but":[152],"did":[153],"not":[154],"improve":[156],"bioavailability.":[158],"most":[160],"promising":[161],"emerge":[164],"HCl":[167],"salt":[168],"5'-valyl":[171],"ester,":[172],"designated":[173],"FV-100.":[175],"Its":[176],"assays":[186],"indicated":[187],"that":[188],"taken":[192],"up":[193],"after":[197],"a":[198],"short":[199],"period":[200],"incubation":[202],"limited":[204],"exposure":[205],"vivo":[209],"may":[210],"have":[211],"beneficial":[212],"effects.":[213],"CONCLUSIONS:":[214],"On":[215],"basis":[217],"its":[219],"favourable":[220],"antiviral":[221],"pharmacokinetic":[223],"properties,":[224],"FV-100":[225],"now":[227],"being":[228],"pursued":[229],"BCNA":[233],"candidate":[234],"treatment":[237],"VZV":[239],"shingles.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2159192124","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
